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S u m m a r y
Current WHO diagnostic criteria according to which the threshold for osteoporosis diag-
nosis is a T-score ≤ -2.5, are unsatisfactory because, according to this criterion 70% persons, 
who suffered fractures had excluded osteoporosis. In 2010, the National Bone Health Alli-
ance published expanded criteria on assumption those who have elevated fracture risk shul 
be treated. This position has been adopted to Polish population by Group of Experts on Os-
teoporosis at the National Consultants for Rheumatology in 2015, and following guidelines 
has been proposed. Osteoporosis should be diagnosed in postmenopausal women (over 
the age of 50 years) and in men over the age of 65 years who fulfil one of condition:
– without fractures, DXA T-score ≤ -2.5 SD,
– low-trauma hip fracture without a BMD measurement,
– major low-trauma fracture (vertebral, hip, proximal humerus, also in some cases 
distal forearm fracture) and osteopenia or osteoporosis (at the spine or hip),
– without fractures (or with fractures), FRAX BMD > 10% (FRAX for polish population).
S t r e s z c z e n i e
Dotychczasowe kryteria osteoporozy WHO przyjmujące za próg rozpoznania wartość 
wskaźnika T ≤ -2,5 są stanowczo niewystarczające. 70% złamań dokonuje się u osób, któ-
re według tego kryterium nie mają osteoporozy. Powoduje to, że większość osób, którym 
grozi ryzyko złamania, nie jest leczona i zmniejszenie liczby złamań jest niewystarczające. 
W roku 2010 grupa robocza National Bone Health Alliance (NBHA) zaproponowała posze-
rzenie kryteriów diagnostycznych, wychodząc z założenia, że osteoporoza powinna być 
rozpoznawana u osób, którym grozi złamanie. Powyższe kryteria zostały zaadaptowane do 
warunków w Polsce przez Zespół Ekspertów ds. Osteoporozy przy Konsultancie Krajowym 
ds. Reumatologii, który w roku 2015 zaproponował poszerzenie kryteriów osteoporozy. Po-
winna być ona rozpoznawana u pacjentów spełniających jedno z poniższych kryteriów:
– bez złamań, DXA T-score ≤ -2,5,
– złamanie niskoenergetyczne bliższego końca kości udowej (bkku), bez badania DXA,
– złamanie niskoenergetyczne w lokalizacji głównej: kręgosłup, bkku, bliższy koniec 
kości ramiennej, także niektóre przypadki złamania kości przedramienia oraz oste-
openia lub osteoporoza w badaniu DXA kręgosłupa lub biodra,
– bez złamań (lub ze złamaniami), FRAX BMD > 10% (FRAX dla populacji polskiej).
Powyższe stanowisko zostało przekazane Ministerstwu Zdrowia i Opieki Społecznej 
w Polsce.
WHO DIAGNOSTIC CRITERIA 
OF OSTEOPOROSIS
The existing diagnostic criteria of osteoporosis are 
based on the bone mineral density (BMD) results. They 
stem from the WHO definition of osteoporosis from 
1993 according to which osteoporosis is defined as 
a systemic metabolic skeletal disease characterised by 
low bone mass and microarchitectural deterioration of 
bone tissue with a consequent increase in bone fragil-
ity and susceptibility to fractures.
According to these criteria osteoporosis should be 
diagnosed in patients with T-score in the proximal fe-
mur (hip) or the spine equal to or less than -2.5 SD (1). 
The WHO working group set the level of -2.5 SD 
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arbitrarily on the basis of epidemiological data indicat-
ing that 95% of fractures occur in these ranges (2). This 
relationship applies only to proximal femur however, af-
ter a long-lasting debate it was determined that osteo-
porosis can also be diagnosed based on the results of 
measurements in the spine.
Clinical trials carried out since the 1990s confirmed 
the validity of this change. The inclusion criterion in 
most studies was the value of T-score equal to or less 
than -2.5 SD in the spine or femoral neck, and in this 
population the antifracture efficacy of the tested medi-
cations was demonstrated.
The great advantage of the densitometric examina-
tion is the ability to quantify the degree of loss of bone 
mineral density by means of a very precise method (er-
ror tolerance in DXA 1-3%) (3).
PROBLEMS ARISING FROM THE CURRENT 
CRITERIA
It is  known that the reduction of bone mineral den-
sity is one of the strongest risk factors of fractures and 
the decrease in BMD by 1 SD entails 2.5-fold increase 
in the risk of fracture (tab. 1) (4, 5). Unfortunately, as it 
turned out, 70% of fractures occur in individuals who 
do not fall under the diagnosis of osteoporosis based 
on the densitometry result (6).
Therefore, on the basis of DXA a person in a real 
risk of a fracture can be considered “healthy”, despite 
the fact that this group of patients is most vulnerable to 
fractures and should be treated.












Distal radius 1.7 1.8 1.7 1.4
Femoral neck 1.4 2.6 1.8 1.6
Lumbar spine 1.5 1.6 2.3 1.5
The fundamental question arises: what “disease” 
should be diagnosed in a 50-year-old woman who 
sustained an osteoporotic fracture and the result of 
DXA excludes osteoporosis? As a consequence of 
this shortcoming of the WHO definition, most people 
with elevated risk of a fracture remain untreated. At the 
same time, there is no established therapy for those 
who have T-score greater than -2.5 SD and there is no 
research in this area.
 DIAGNOSIS OF FRACTURE RISK USING FRAX
The introduction of the FRAX tool for the assessment 
of fracture risk in 2008 was a major advance in diagnos-
tics of osteoporosis. The FRAX method allows to deter-
mine the risk of fracture based on BMD or BMI as well 
as known fracture risk factors, such as: prevalent low-
energy fractures, family history of fractures, smoking, 
corticosteroid therapy, alcoholism, rheumatoid arthritis.
FRAX calculations are based on the results of a pro-
spective study on 230,486 subjects. Currently, 62 mod-
els exist in 57 countries. It is estimated that 78% of the 
world’s population is embraced by FRAX, and the an-
nual number of individual calculations reaches 3.5 mil-
lion (7, 8).
POSITION STATEMENT OF THE NATIONAL BONE 
HEALTH ALLIANCE WORKING GROUP
In 2010, the National Bone Health Alliance (NBHA) 
was appointed in the USA. The NBHA is a public-private 
partnership comprising representatives of 54 organiza-
tions, including 35 scientific societies (ASBMR, NOF, 
AAOS), 16 private institutions and 4 government agen-
cies: NIH (National Institute of Health), the FDA (Food 
and Drug Administration), Centers for Disease Control 
and Prevention, NASA.
The aim of the group was, among others, to estab-
lish diagnostic criteria for osteoporosis in women over 
the age of 50 years. As a principle, the group has not 
dealt with therapeutic issues.
According to NBHA Working Group the diagnosis of 
osteoporosis should be established in postmenopaus-
al women and in men over the age of 50 if any of the 
following factors occur:
 – T-score ≤ -2.5 SD (at the spine or hip),
 – low-trauma hip fracture without a BMD measure-
ment,
 – low-trauma fracture (vertebral, proximal humerus, 
pelvis, or in some cases, distal forearm fracture) 
in patients with osteopenia,
 – elevated fracture risk based on FRAX in patients with 
osteopenia (level established for each country sepa-
rately). In USA FRAX > 20% for major fracture (9).
These criteria were adopted by the NOS and are 
used in the USA.
Currently, there is a wide-ranging discussion over 
the legitimacy of broadening the criteria.
Prof. John Kanis maintains that fracture risk cannot 
be equated with the diagnosis of osteoporosis just as 
it is impossible to recognize a myocardial infarction 
based on the risk of its occurrence. This stance re-
sults from the assumption that osteoporosis is strictly 
a bone disease and it can be only diagnosed on the 
basis of the parameters evaluating the bone itself.
The non-invasive methods presently available are: 
densitometric examination, ultrasound, X-ray, MRI. Un-
fortunately, they do not provide satisfactory diagnostic 
capabilities. This also applies to micro X-ray. TBS (Tra-
becular Bone Score) offers some degree of promising 
potential (10).
Invasive methods include a microindentation and bi-
opsy. Microindentation is a direct measurement meth-
od of evaluating bone mechanical properties by means 
of inserting a probe and reaching to a pelvis plate for 
indentation. This method is very rarely used (11). The 
most reliable method would undoubtedly be bone bi-
opsy however, this is an invasive procedure. Bone biop-
sy involves morphometry of obtained bone specimens, 
which provides comprehensive information about the 
static and dynamic remodeling of bone. Regrettably, 
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there is no data that would allow to determine fracture 
risk on this basis. Therefore, we could diagnose osteo-
porosis without assessment of fracture risk (12).
DOES LOW-ENERGY FRACTURE INDICATE 
THE DIAGNOSIS?
As per the definition a low-energy fracture is recog-
nized when a fracture is a result of a fall from own height. 
This clear definition is not devoid of weaknesses.
A completely different energy is involved when 
a 50-year women old undergoes a radial fracture when 
falling on concrete; quite different when a 85-year-old 
woman endures the same injury falling at home on a car-
pet. However, after each fracture the risk of subsequent 
fractures increases 2.5 times (tab. 2) (13). The question 
then arises whether osteoporosis should be diagnosed in 
any patient who has suffered a low-energy fracture. Given 
the variety of fractures and their circumstances, it seems 
that this could result in overdiagnosis of osteoporosis.
Tab. 2. Prior fractures and increased fracture risk (13)
Increased risk of fracture after fracture
Location of 
prior fracture
Location of subsequent fracture
Hip Vertebral Wrist Other
Hip 2.3 2.5 1.4 1.9
Vertebral 2.3 4.4 1.4 1.8
Wrist 1.9 1.7 3.3 2.4
Other 2.0 1.9 1.8 1.9
The most reasonable solution is to incorporate ma-
jor fractures as in the FRAX model, that is: proximal 
femur, spine, proximal end of the humerus, the distal 
end of the radius. It should also be emphasized that 
every person who has sustained a low-energy fracture 
categorically requires preventive measures of subse-
quent fractures.
THE POSITION OF THE GROUP OF EXPERTS 
ON OSTEOPOROSIS AT THE NATIONAL 
CONSULTANTS FOR RHEUMATOLOGY, 
WARSAW 2015
According to experts (J. Badurski, M. Bolanowski, 
E. Czerwiński, A. Dębski, P. Głuszko, M. Jabłoński, 
K. Księżoposlka-Orłowska, R. Lorenc, E. Marcinowska, 
W. Marczynski, W. Tłustochowicz), in postmenopausal 
women (over the age of 50 years) and in men over the 
age of 65 years the decisive criteria for the diagnosis of 
osteoporosis should be (one of the following):
 – without fractures, DXA T-score ≤ -2.5 SD,
 – low-trauma hip fracture without a BMD measure-
ment,
 – major low-trauma fracture (vertebral, hip, proxi-
mal humerus, also in some cases distal forearm 
fracture) and osteopenia or osteoporosis (at the 
spine or hip),
 – without fractures (or with fractures), FRAX BMD 
> 10% (FRAX for polish population) (14).
 CONCLUSIONS
There is no doubt that the current WHO diagnostic 
criteria according to which the threshold for osteopo-
rosis diagnosis is a T-score ≤ -2.5, are unsatisfactory.
According to this method as a “healthy” are con-
sidered 70% persons, which in fact suffered frac-
tures. Thus, the revision of the criteria is an inherent 
need of the moment, to cover proper treatment of 
the population.
There is still an open question to what extent the 
risk of disease may be referred to as its definition.
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